A leucine zipper 'molecular glue' system for attaching proteins to cell-penetrating peptides delivered p53 to cell nuclei and inhibited cancer cell growth more efficiently than a directly fused conjugate.
Outperformed direct fusionThe leucine zipper-mediated CPP delivery of p53 inhibited cancer cell proliferation more efficiently than a directly fused p53-CPP conjugate, demonstrating the advantage of modular, non-covalent cargo attachment.
What the researchers found
The heterodimeric leucine zipper system (LzK/LzE) formed a 1:1 hybrid in solution, confirmed by fluorescence spectroscopy, effectively conjugating cargo proteins to cell-penetrating peptides without covalent modification.
When used to deliver p53 (p53-LzK/LzE-CPP), the hybrid localized to cell nuclei and inhibited cell-specific proliferation across multiple cell lines. Critically, the leucine zipper delivery system outperformed the directly fused p53-CPP conjugate in proliferation inhibition, suggesting that the non-covalent, modular attachment preserves protein cargo activity better than direct fusion.
Why it matters
Most protein-based drugs can't cross cell membranes, severely limiting their therapeutic use. This leucine zipper system offers a modular, plug-and-play approach to intracellular protein delivery — any protein can be attached to any CPP without altering either component. The fact that it outperformed direct fusion means it better preserves the therapeutic protein's activity, which has been a persistent challenge in the field.
The numbers in context
1:1 zipper hybrid; p53 nuclear localization; zipper system outperformed direct p53-CPP fusion in proliferation inhibition
How the study worked
Researchers prepared two components: an EGFP or p53 protein fused to an acidic leucine zipper (LzK), and a basic leucine zipper (LzE) conjugated to a cell-penetrating peptide. Hybrid formation was confirmed by fluorescence spectroscopy and titration. Cellular delivery was assessed by fluorescence microscopy for EGFP and by cell proliferation assays for p53 across multiple cell lines. Results were compared against directly fused p53-CPP conjugates.
Who was studied
Multiple mammalian cell lines including mouse cells
What this study cannot tell us
This is entirely an in vitro cell culture study with no animal testing. The leucine zipper adds molecular weight that could affect in vivo pharmacokinetics, stability, and biodistribution. Serum stability of the zipper hybrid was not assessed. Whether the non-covalent zipper connection remains stable in blood circulation is unknown. Only p53 and EGFP were tested as cargo proteins.
How to read the evidence
This is an in vitro proof-of-concept study demonstrating the delivery system's functionality in cell culture. While the results are clear and well-characterized, no animal testing has been performed, placing this at an early development stage.
When this study was published
Published in 2021, this study introduces a delivery concept that remains relevant to the growing field of intracellular protein therapeutics.
The bigger picture
Intracellular protein delivery is one of the holy grails of drug delivery. While cell-penetrating peptides have shown promise, connecting them to protein cargos without destroying the cargo's function has been difficult. This leucine zipper approach adds a versatile new tool to the protein delivery toolkit, complementing other approaches like antibody-drug conjugates and lipid nanoparticles for delivering biological therapeutics to intracellular targets.
Questions still open
- Does the leucine zipper hybrid remain stable enough in blood to deliver proteins to tumors in vivo?
- Could this modular system be adapted for delivering other therapeutic proteins like CRISPR enzymes or transcription factors?
- How does the immunogenicity of the leucine zipper components compare to other protein delivery approaches?
Common questions
What is a leucine zipper and how does it help deliver drugs into cells?
Why is this approach better than directly fusing proteins to cell-penetrating peptides?
Read the original research
Complementary leucine zippering system for effective intracellular delivery of proteins by cell-penetrating peptides.
Bioorganic & medicinal chemistry, 33, 116036
Citation
Kitamatsu, Mizuki; Yuasa, Hiroki; Ohtsuki, Takashi; Michiue, Hiroyuki. (2021). Complementary leucine zippering system for effective intracellular delivery of proteins by cell-penetrating peptides.. Bioorganic & medicinal chemistry, 33, 116036. https://doi.org/10.1016/j.bmc.2021.116036